Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

GALTGALT
Showing 4 of 9 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in GALECTIN THERAPEUTICS INC

Yes. Two Sigma holds 318,245 shares of GALT (Galectin Therapeutics), worth $1.5M, as of its Q2 2026 13F filing. It reduced the position by 148,818 shares (-31.9%) from Q1 2026. Two Sigma has held GALT since Q3 2025, across 4 quarterly 13F filings.

Current Value

$1.5M

Current Shares

318,245

Total Value Change

+$1.4M

Total Shares Change

+301,598

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
318,245
-31.9%
$1.5M0.0%$4.64
0
2026-Q1
Increased
467,063
+2711.6%
$1.3M0.0%$2.79
41
2025-Q4
Decreased
16,612
-0.2%
$69,1060.0%$4.16
0
2025-Q3
New
16,647
-
$70,5000.0%$4.24
29

Other major holders of GALT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, OSAIC HOLDINGS, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used